Skip to main content
PMC home page
Scientific Reports logoLink to Scientific Reports
. 2017 Aug 3;7:7191. doi: 10.1038/s41598-017-07497-x

Ndrg1 promotes adipocyte differentiation and sustains their function

Kai Cai 1, Rabih El-Merahbi 1, Mona Loeffler 1, Alexander E Mayer 1, Grzegorz Sumara 1,✉
PMCID: PMC5543145  PMID: 28775290

Abstract

Adipocytes play a central role in maintaining metabolic homeostasis in the body. Differentiation of adipocyte precursor cells requires the transcriptional activity of peroxisome proliferator-activated receptor-γ (Pparγ) and CCAAT/enhancer binding proteins (C/Ebps). Transcriptional activity is regulated by signaling modules activated by a plethora of hormones and nutrients. Mechanistic target of rapamacin complexes (mTORC) 1 and 2 are central for the coordination of hormonal and nutritional inputs in cells and are essential for adipogenesis. Serum glucocorticoid kinase 1 (Sgk1)-dependent phosphorylation of N-Myc downstream-regulated gene 1 (Ndrg1) is a hallmark of mTORC2 activation in cells. Moreover, Pparγ activation promotes Ndrg1 expression. However, the impact of Ndrg1 on adipocyte differentiation and function has not yet been defined. Here, we show that Ndrg1 expression and its Sgk1-dependent phosphorylation are induced during adipogenesis. Consistently, we demonstrate that Ndrg1 promotes adipocyte differentiation and function by inducing Pparγ expression. Additionally, our results indicate that Ndrg1 is required for C/Ebpα phosphorylation. Moreover, we found that Ndrg1 phosphorylation by Sgk1 promotes adipocyte formation. Taken together, we show that induction of Ndrg1 expression by Pparγ and its phosphorylation by Sgk1 kinase are required for the acquisition of adipocyte characteristics by precursor cells.

Introduction

White adipocytes are central for the regulation of lipid and metabolic homeostasis1. Importantly, both deficits in adipose tissue development (lipodystrophy) and the excessive accumulation of adipose tissue result in metabolic disorders, including type 2 diabetes2. Differentiation of mesenchymal precursor cells into adipocytes is crucial for adipose tissue acquisition2. The terminal differentiation of adipocytes requires the coordinated expression of genes regulating their specific functions. Peroxisome proliferator-activated receptor-γ (Pparγ) and CCAAT/enhancer binding proteins (C/Ebps) are major transcription factors promoting the acquisition of molecular adipocyte characteristics by precursor cells2. A plethora of extracellular signals, including hormones and nutrients, activate intracellular signaling cascades that modulate Pparγ, C/Ebps and other transcription factors to regulate adipogenesis3.

Mechanistic target of rapamycin (mTOR) activity is dependent on both hormones (insulin) and nutrients levels4. In cells, mTOR kinase is present in two large multi-component signaling complexes; mTORC1 and mTORC2 (mTOR complex 1 and 2). mTORC1 is defined primarily by raptor protein, while mTORC2 by the presence of the rictor subunit. Depletion of raptor specifically abrogates the activity of mTORC1, while rictor is specifically required for mTORC2 function4. Genetic and pharmacological studies revealed that both mTORC1 and mTORC2 are required for adipogenesis and promote adipocyte function5–8. Yet, the function of distal mTORC effectors in the regulation of adipocyte formation is not completely understood.

mTORC2 activates Sgk1, which is required for adipocyte formation9–12. Ndrg1 is a major phosphorylation target of Sgk113–15. Moreover, expression of Ndrg1 in adipocytes seems to be promoted by Pparγ16, 17. Ndrg1 was previously implicated in regulation of progression of multiple tumors18–22, peripheral neuropathy23, 24, T cell anergy25, as well as bone remodeling and macrophage differentiation26. Additionally, a number of studies suggest that Ndrg1 might regulate other signaling cascades that influence adipocyte differentiation. This includes the Wnt/β-Catenin cascade, glycogen synthase kinase 3β (Gsk3β), as well as extracellular regulated kinase 1/2 (Erk1/2)3, 27–29. However, the impact of Ndrg1 on the regulation of adipogenesis and adipocyte function has not been elucidated. Here, we show that Ndrg1 promotes adipogenesis and sustains adipocyte function by promoting Pparγ expression and possibly C/Ebpα activity. Moreover, our results suggest that Sgk1-dependent phosphorylation of threonine 346 on Ndrg1 promotes adipocyte differentiation.

Results

Ndrg1 is induced during adipocyte differentiation

To test whether Ndrg1 could regulate adipocyte differentiation, we first measured its expression in the 3t3l1 pre-adipocyte cell line, which was subjected to an adipocyte-differentiation cocktail for different time points. Expression of Ndrg1 mRNA increased progressively during differentiation, reaching more than 10-fold elevation in fully differentiated cells compared to undifferentiated 3t3l1 cells (Fig. 1A). Previous studies indicated that Ndrg1 is a target of the master transcription factor promoting adipogenesis – Pparγ16, 17. In fact, 3t3l1 cells differentiated in the presence of the Pparγ agonist rosiglitazone present markedly higher expression of Ndrg1 after 8, 12 and 14 days of differentiation (Fig. 1A). Consistently, protein levels for Ndrg1 also increased during 3t3l1 differentiation (Fig. 1B).

Figure 1.

Figure 1

Open in a new tab

Ndrg1 promotes adipocyte differentiation and lipolysis. (A) Expression of Ndrg1 mRNA in 3t3l1 cells at different stages of differentiation with or without rosiglitazone (Rosi). Stars indicate significance between expression levels in control and Rosi-treated cells at the specific time points (*P < 0.05, **P < 0.01, ***P < 0.001 according to a t-test). (B) Total and phospho-Ndrg1 levels at different stages of 3t3l1 differentiation. (C) Ndrg1 protein levels in cells targeted by different shRNAs against Ndrg1 (Ndrg1 sh). (D) Relative TG content and (E) neutral lipid staining (OilRedO) on differentiated 3t3l1 cells after knockdown of Ndrg1. (F) Lipogenesis rate in control and Ndrg1 sh cells, unstimulated (unstim.) or upon insulin (Ins.) stimulation. (G) Relative glycerol and (H) FFA levels in medium from differentiated 3t3l1 control cells or Ndrg1 knockdown cells stimulated with control medium or isoproterenol (Iso). For all graphs, each data point represents a biological replicate. Stars indicate significance for given parameters between control and Ndrg1-depleted cells. (*P < 0.05, **P < 0.01, ***P < 0.001 according to ANOVA followed by the Post hoc Tukey test).

Upon mTORC2-dependent activation of Sgk1 kinase, Sgk1 phosphorylates Ndrg1 at five residues (S300, T328, T346, T346 and T366)13–15. Importantly, using a phospho-specific antibody, we found that the levels of Ndrg1 phosphorylated by Sgk1 on T346 also increased during adipocyte differentiation (Fig. 1B). These results suggest that Ndrg1 could play an important role in the regulation of adipocyte differentiation, function, or both.

Ndrg1 is required for adipocyte differentiation

To assess the role of Ndrg1 in adipocyte differentiation, we generated stable 3t3l1 cell lines expressing shRNA against Ndrg1. Expression of shRNA sequence 3 and 4 against Ndrg1 (Ndrg1 sh3 and sh4) resulted in efficient knockdown of Ndrg1 protein (Fig. 1C). Using AdipoRed-mediated triglyceride (TG) quantification and neutral lipid OilRedO staining, we demonstrated that knockdown of Ndrg1 in 3t3l1 cells subjected to 14 days of adipogenic differentiation resulted in roughly 50% reduced lipid accumulation compared to control cells (Fig. 1D and E). Consistently, de novo lipid production (lipogenesis) was also markedly reduced in the absence of Ndrg1 (Fig. 1F). Next, we tested whether Ndrg1 deficiency also impacts other functions of adipocytes. To assess the release of TG stored in lipid droplets during the process of lipolysis, we measured the levels of glycerol and free fatty acids (FFAs) released to the cell culture medium from differentiated 3t3l1 cells. Lipolysis was markedly reduced in the absence of Ndrg1 (Fig. 1G and H). Indicating that also adipocytes function is affected by depletion of Ndrg1.

Ndrg1 promotes the expression of Pparγ and phosphorylation of C/Ebpα

Next, we tested the expression levels of key transcription factors regulating adipocyte differentiation. mRNA levels of Pparγ were markedly reduced in cells expressing shRNA against Ndrg1 (Fig. 2A). Induction of C/Ebpα transcriptional activity is also required for proper adipocyte differentiation3, however depletion of Ndrg1 did not influence C/Ebpα mRNA expression. Moreover, the levels of transcriptional targets of Pparγ were reduced in cells depleted from Ndrg1 (Fig. 2A), including diacylglycerol acyltransferase (Dgat) as well as two crucial lipases promoting lipolysis, adipose triglyceride lipase (Atgl) and hormone sensitive lipase (Hsl)30–32. Consistently, Pparγ protein levels were markedly reduced in the absence of Ndrg1 (Fig. 2B –without cycloheximide and Supplementary Fig. 1). To test if Ndrg1 also regulates the stability of Pparγ protein, we subjected Ndrg1-deficient 3t3l1 cells to a cycloheximide chase experiment. Cycloheximide treatment resulted in a higher rate of disappearance of Pparγ, in Ndrg1-deficient cells, indicating that Ndrg1 promotes Pparγ stability (Fig. 2B and C). Next, we differentiated Ndrg1-depleted and control 3t3l1 cells in the adipocyte differentiation cocktail supplemented with different concentrations of Pparγ agonists (rosiglitazone, troglitazone). Both agonists markedly induced TG accumulation in 3t3l1 control and Ndrg1-deficient cells. However, treatment with Pparγ agonists did not fully abrogate the difference in TG content between control and Ndrg1-deficient cells (Fig. 2D), suggesting that Ndrg1 could additionally promote the differentiation of adipocytes by targeting other factors than Pparγ.

Figure 2.

Figure 2

Open in a new tab

Ndrg1 promotes Pparγ expression and stability as well as C/Ebpα phosphorylation. (A) Relative mRNA levels for indicated genes in control and Ndrg1-deficient differentiated 3t3l1 cells. (n = 3, *P < 0.05, **P < 0.01, ***P < 0.001 according to t-test). (B) Western blot for Pparγ and Gapdh in control and Ndrg1-depleted differentiated 3t3l1 cells stimulated with cycloheximide for indicated time points. Representative picture was chosen from three biological replicates. (C) Quantification of relative amount of Pparγ in cells treated with cycloheximide in relation to the initial (without treatment) levels of Pparγ in respective control and Ndrg1-depleted cells (n = 3, *P < 0.05, **P < 0.01 according to t-test). (D) Relative TG content in control and Ndrg1 sh 3t3l1 cells subjected to adipocyte differentiation cocktail with rosiglitazone (Rosi) or troglitazone (Tro). Each data point represents a biological replicate. Stars indicate significance for given parameters between control and Ndrg1-depleted cells. (*P < 0.05, **P < 0.01, ***P < 0.001 according to ANOVA followed by the Post hoc Tukey test). (E) Western blot analysis using indicated antibodies in control and Ndrg1-deficient cells stimulated with insulin (Ins.) for the indicated time.

Previous studies indicated that Ndrg1 might regulate Gsk3β and Erk1/2 activity, as well as the Wnt/β-Catenin pathway27. Gsk3β and Erk1/2 have been shown to promote adipogeneis33, 34, while expression of β-Catenin suppresses pre-adipocyte differentiation35. We tested expression and activation of these proteins in cells depleted of Ndrg1. Western blot analysis revealed that Ndrg1 depletion does not influence the activation or levels of Erk1/2 (Fig. 2E and Supplementary Fig. 1). Similarly, levels of phosphorylated (inactive) and total Gsk3β, as well as β-Catenin were not altered by Ndrg1 silencing (Fig. 2E and Supplementary Fig. 1). Interestingly, Gsk3β promotes phosphorylation of C/Ebpα on threonine 222/22633. Therefore, we tested whether Ndrg1 is required for C/Ebpα phosphorylation. We observed that depletion of Ndrg1 suppresses basal and insulin stimulated phosphorylation of C/Ebpα on threonine 222/226, but does not influence total C/Ebpα protein levels (Fig. 2E).

These results suggest that Ndrg1 promotes adipogenesis by enhancing Pparγ expression. In addition, Ndrg1 might also influence C/Ebpα activity through phosphorylation. However, the precise mechanisms of Ndrg1 action needs to be determined.

Overexpression of Ndrg1 promotes adipocyte differentiation

To determine if overexpression of Ndrg1 is sufficient to enhance adipogenesis, we generated 3t3l1 cells ectopically expressing Flag-tagged Ndrg1 (FlagNdrg1). Stable expression of FlagNdrg1 was confirmed by Western blotting (Fig. 3A). Overexpression of Ndrg1 resulted in an over two-fold elevation in the levels of TG in differentiated 3t3l1 cells compared to control cells (Fig. 3B and C). On the molecular level, overexpression of Ndrg1 lead to elevated levels of markers defining adipocyte function. Specifically, we observed increased expression of Pparγ, Dgat, stearoyl-CoA-desaturase (Scd1), acetyl-CoA carboxylase (Acc1), Atgl, Hsl, monoglyceride lipase (Mgl), adiponectin and leptin (Fig. 3D). Moreover, Ndrg1 overexpression enhanced adipocyte function as indicated by increased lipolytic activity (Fig. 3E and F). Altogether, these data suggest that Ndrg1 overexpression promotes adipogenesis and adipocyte function.

Figure 3.

Figure 3

Open in a new tab

Overexpression of Ndrg1 promotes adipogenesis. (A) Western blot using indicated antibodies on extracts isolated from 3t3l1 control and FlagNdrg1-expressing cells. (B) Relative TG content and (C) neutral lipid staining (OilRedO) of differentiated 3t3l1 control and FlagNdrg1-expressing cells. (D) Relative mRNA levels for indicated genes in differentiated control and Ndrg1-overexpressing 3t3l1 cells. (F) Relative glycerol and (G) FFA levels in medium from differentiated 3t3l1 control cells or Ndrg1-overexpressing cells stimulated with control medium or Iso. Each data point represents a biological replicate (for bar plots n = 3). Stars indicate significance for given parameters between control and Ndrg1- overexpressing cells. (*P < 0.05, **P < 0.01, ***P < 0.001 according to ANOVA followed by the Post hoc Tukey test).

Sgk1-dependent phosphorylation of Ndrg1 on T346 is required for adipogenesis

As a downstream effector of mTORC2, Sgk1 phosphorylates Ndrg1 on multiple sites (S300, T328, T346, T356 and T366)13–15. Previous studies indicated that Sgk1 is required for adipocyte differentiation11. To test if Sgk1-dependent phosphorylation of Ndrg1 is required for its function, we generated Ndrg1 alanine mutants that cannot be phosphorylated at the respective residues and expressed them in 3t3l1 cells. Western blot analysis confirmed that all mutants were equally overexpressed as the control wild type form of Ndrg1 (Fig. 4A). Next, we subjected all the cell lines to an adipogenic differentiation protocol. As expected, overexpression of the wild type form of Ndrg1 resulted in markedly elevated TG accumulation compared to cells expressing empty vector (Fig. 4B). Overexpression of S300A, T328A, T356A and T366A mutants also resulted in a marked increase in TG accumulation in cells, comparable to wild-type overexpression (Fig. 4B). However, overexpression of the T346A mutant led to markedly lower TG accumulation than cells overexpressing the wild-type form of Ndrg1 (Fig. 4B). These results indicate that Sgk1-dependent phosphorylation of Ndrg1 on T346 promotes adipogenesis.

Figure 4.

Figure 4

Open in a new tab

Sgk1-dependent phosphorylation of Ndrg1 is required for its pro-adipogenic function. (A) Western blot assessing the levels of expression of different FlagNdrg1 phospho-mutant proteins using the indicated antibodies. (B) Relative TG content in differentiated 3t3l1 cells expressing the indicated phospho-mutants of Ndrg1. Each data point represents an average TG content of individually generated and differentiated mixed stable cell populations of 3t3l1 cells expressing different Ndrg1 mutants. (*P < 0.05 according to ANOVA followed by the Post hoc Tukey test).

Ndrg1 sustains adipocyte function after differentiation

To test if Ndrg1 plays a role in the regulation of mature adipocyte function, we knocked down Ndrg1 using transient siRNA transfection in fully differentiated 3t3l1 cells. Effective knockdown of Ndrg1 was confirmed by Western blot (Fig. 5A). Consistent with our previous results, siRNA-mediated silencing of Ndrg1 resulted in a reduced rate of lipogenesis (Fig. 5B). Moreover, knockdown of Ndrg1 decreased the rate of isoproterenol-induced lipolysis in 3t3l1 cells, as indicated by a more than two-fold reduction in the concentration of FFAs and a more than three-times reduced levels of glycerol in the medium compared to control cells (Fig. 5C and D). To confirm these results, we knocked down Ndrg1 in adipocytes differentiated from primary stromal vascular cells isolated from wild type mice. Ndrg1 knockdown in primary cells resulted in a similarly reduced rate of lipolysis (Fig. 5E), demonstrating that the observed phenotype is not restricted to 3t3l1 cells.

Figure 5.

Figure 5

Open in a new tab

Ndrg1 promotes lipolysis independent of its impact on adipocyte differentiation. (A) Western blot for the indicated proteins in differentiated 3t3l1 cells transfected with control or Ndrg1 siRNA. (B) Lipogenesis rate in control siRNA and Ndrg1 siRNA transfected cells (Ndrg1 si), unstimulated (unstim.) or upon insulin (Ins.) stimulation. (C) Relative glycerol and (D) FFA levels in medium from differentiated 3t3l1 control cells or Ndrg1 siRNA-treated cells stimulated with control medium or Iso. (E) Relative glycerol levels in adipocytes differentiated from primary stroma-vascular cells isolated from subcutaneous fat pads and transfected with non-targeted control (NTC) or Ndrg1 siRNA. Each data point represents a biological replicate. Stars indicate significance for given parameters between control and Ndrg1-depleted cells. (*P < 0.05, **P < 0.01, ***P < 0.001 according to ANOVA followed by the Post hoc Tukey test). (F) Model of Ndrg1 action in adipocytes. mTORC2 activates Sgk1 kinase, which phosphorylates Ndrg1 on T346. Phosphorylated Ndrg1 increases expression of Pparγ through an unknown mechanism to promote adipogenesis and adipocyte function. In a positive feedback loop, Pparγ also promotes Ndrg1 expression and stability. Additionally, Ndrg1 promotes C/Ebpα phosphorylation, which might influence its activity.

Discussion

Our results indicate that Ndrg1 is both activated during and required for adipogenesis. Moreover, in fully differentiated adipocytes Ndrg1 stimulates lipolysis. Ndrg1 promotes adipocyte formation partially by enhancing expression of the crucial pro-adipogenic transcription factor Pparγ. However, Ndrg1 might also regulate C/Ebpα adipogenic activity (Fig. 5F).

Ndrg1 is a distal effector of mTORC2 activation in cells9. Disruption of mTORC signaling by silencing its component rictor results in reduced adipocyte differentiation6. Sgk1 kinase is directly activated by mTORC2; consistently, its depletion results in attenuated adipogenesis9–12. In agreement with these data, we showed that Sgk1-dependent phosphorylation of Ndrg1 is required for its pro-adipogenic function. However, previous results indicate that the mTORC2 signaling module suppresses lipolysis36. As our results indicate that Ndrg1 promotes lipolysis, mTORC2 must therefore suppress lipolysis by utilizing an Ndrg1-independent mechanism. Of note, expression of Atgl and Hsl, which are targets of Pparγ31, 32 were reduced in the absence of Ndrg1. These results explain the attenuated lipolysis rate in the absence of Ndrg1. Moreover, our results might indicate that defective lipolysis in cells deficient for Ndrg1 may be a direct consequence of reduced differentiation of these cells. We showed that Pparγ activation increases Ndrg1 expression. On the other hand, our results indicate that Ndrg1 promotes expression and stability of Pparγ. Therefore we postulate that Ndrg1 acts as a component of a positive feedback loop promoting Pparγ action.

However, agonist-mediated activation of Pparγ did not completely rescue the adipogenesis defect in Ndrg1-deficient cells. This might be caused by the lower protein levels of Pparγ in cells depleted of Ndrg1. Alternatively, this might indicate that Ndrg1 also regulates other components of the molecular machinery defining adipocyte differentiation. In fact, we observed that phosphorylation of C/Ebpα on threonines 222/226 is markedly reduced in the absence of Ndrg1. Threonines 222 and 226 on C/Ebpα were originally identified as targets for Gsk3β-dependent phosphorylation33. However, a recent study indicated that C/Ebpα is a poor substrate for Gsk3β37. In fact, our results suggest that Ndrg1 does not influence the total levels of Gsk3β or its phosphorylated (inactive) form. This suggests that Ndrg1 modulates C/Ebpα phosphorylation by influencing Gsk3β activity in another manner or by utilizing a Gsk3β-independent mechanism. Also, the impact of C/Ebpα T222/T226 phosphorylation on adipogenesis has not been directly assessed. Phosphorylation on these sites was originally proposed to enhance adipogenesis33, but a recent study indicates that it might reduce C/Ebpα activity37.

Previous studies implicated Ndrg1 in the regulation of Wnt/β-Catenin as well as Erk1/2 action27. Our results indicate that Ndrg1 does not influence any of these pathways in adipocytes. Therefore, we postulate that Ndrg1 primarily promotes adipogenesis by enhancing expression of Pparγ. However, Ndrg1 might also influence other adipogenic factors and the exact mechanism of its action needs to be defined further.

Methods

Pre-adipocyte culture and differentiation

3t3l1 preadipocytes were cultured in DMEM supplemented with 10% fetal calf serum (FCS), and 40 μg/ml Gentamicin at 37 °C in a humidified atmosphere. For differentiation, 3t3l1 were grown to confluency. Two days post-confluency, the cells were switched to medium containing 10% fetal bovine serum, 1.5 µg/ml insulin, 0.5 mM 3-isobutyl-1-methylxanthine (IBMX) and 1 μM Dexamethasone (Dex) for 48 hours. This step was repeated for an additional 48 hours and then the induced cells were incubated with “Differentiation Medium” (DMEM supplemented with 10% FBS and 1.5 µg/ml insulin) for up to 10 days to achieve differentiation to adipocytes. In the indicated experiments, Pparγ agonists (rosiglitazone or troglitazone) were supplemented to the differentiation medium at indicated concentrations throughout the differentiation process. Fresh agonists were added to the medium every 48 h. All compounds were purchased from Sigma-Aldrich if not specified.

Stromal vascular cells (SVCs) containing pre-adipocytes were isolated from adipose tissue Briefly, subcutaneous white adipose tissue were collected from wild type BL6 mice and cut into small fragments with a scalpel. The sliced SVC fractions were treated with 2 mg/ml Collagenase D (Roche) in PBS containing 5 mM CaCl2, 1% BSA and P/S with shaking (300 rpm) at 37 °C for 40 minutes. After digestion of adipose tissue, the solution was filtered through a cell strainer with 45 μm pore size and centrifuged at 1250 rpm for 10 minutes to collect SVCs. SVCs were cultured in complete medium (DMEM/F12 containing 10% FBS, 1% sodium pyruvate (SP), 1% non-essential amino acids (NEAA) and P/S) until two days post-confluent and transferred into induction medium (DMEM/F12 containing 10% FBS, 1% SP, 1% NEAA and P/S, 0.2 μM Indomethacin, 0.5 μM Rosiglitazone, 0.5 mM IBMX and 1 μM Dex) for two times 48 hours. Then, the SVC cells were cultured into complete medium with 1.5 μg/mL insulin for up to 6 additional days.

siRNA transfection

Fully differentiated 3t3l1 cells were transfected using Dharmafect Duo transfection reagent with siRNA against Ndrg1 or NonTarget control (Dharmacon) according to the manufacturer’s protocol. Cells were used for experiments 48 hours post transfection.

Generation of stable knockdown and overexpression of wild type and mutant Ndrg1

shRNA against Ndrg1 was introduced into 3t3l1 cells using lentiviral particles. Specific shRNA sequences (available in Supplementary Table 1) were cloned in pGIPZ vector was described previously38. The infected 3t3l1 cells were then selected by puromycin treatment (5 μg/ml). The pBabe-Puro vector was used for retrovirus-driven Flag-Ndrg1 expression. A full length coding sequence of Ndrg1 was introduced between EcoRI and BamHI restriction sites of this vector. Platinum-E (Plat-E) cell were utilized to produce retroviral particles. Infected 3t3l1 cells were selected with puromycin (5 μg/ml). Ndrg1 mutants were generated using the site-directed mutagenesis kit from New England Biolabs according to the manufacturer’s protocol.

Analyses of mRNA expression and protein levels

Quantitative polymerase chain reaction (qPCR) was performed using SYBR green Universal PCR master mix (Roche). mRNA was isolated using trizol reagent (Invitrogen). cDNA was generated using First Strand cDNA synthesis kit (Thermo Scientific). Primers used in this study are available in Supplementary Table 1. Western blot analyses were performed according to standard procedure. All antibodies were obtained from Cell Signaling Technology. For indicated experiments, cycloheximide (Sigma, 50 μg/ml concentration) was added to the culture medium to block protein translation. The levels of indicated proteins were assessed by western blot after the indicated time points.

Quantification of lipid levels and DNA content

Double staining of AdipoRed reagent (Lonza, Basel, Switzerland) and Hoechst 33342 (Invitrogen) was utilized to quantify the intracellular lipid accumulation in relation to DNA content. Oil-Red O staining (Sigma) was used to visualize TG in cells. To assay lipolysis, cells were starved for 2 hours in phenol red-free DMEM supplemented with 0.5% BSA, followed by stimulation with 10 μM isoproterenol (iso) (Sigma) for 2 hours in the same medium. FFAs in the medium were quantified using NEFA-reagent from Wako Chemicals and glycerol was quantified using the specific reagent from Sigma.

Lipogenesis assay

For determination of de novo lipogenesis, 3T3L1 cells were incubated with 3H-glucose (1 µCi/mL, Perkin Elmer) in the presence or absence of insulin for 3 h. Cells were washed twice with PBS and lysed in 0.1 N HCl. Lipids were then extracted with chloroform/methanol (2:1, v/v). The lipid-containing chloroform phase was used for liquid scintillation counting.

Statistical analysis

For multiple comparisons, one way analysis of variance (ANOVA) followed by the Post hoc Tukey test was used. For determination of significance between two experimental groups T-Test was used. Significance was accepted at the level of 0.05. Exact statistics are indicated for each figure.

Electronic supplementary material

Supplementary information (748.2KB, pdf)

Acknowledgements

We thank Dr. Ann Wehman, Dr. Olga Sumara and Jonathan Trujillo Viera for critical comments to our manuscript. This project was supported by Emmy Noether grant number Su 820/1-1 from the German Research Foundation. Mona Loeffler, Alexander F Mayer and Grzegorz Sumara are additionally supported by the European Research Council (ERC) Starting Grant SicMetabol.

Author Contributions

Kai Cai performed most of the experiments and contributed to experimental design. Rabih El-Merahbi and Alexander E. Mayer performed some experiments and contributed to experimental design. Mona Loeffler performed some experiments, contributed to experimental design and writing of the manuscript. Grzegorz Sumara was responsible for experimental design and wrote the manuscript.

Competing Interests

The authors declare that they have no competing interests.

Footnotes

Electronic supplementary material

Supplementary information accompanies this paper at doi:10.1038/s41598-017-07497-x

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Rosen ED, Spiegelman BM. What we talk about when we talk about fat. Cell. 2014;156:20–44. doi: 10.1016/j.cell.2013.12.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Cristancho AG, Lazar MA. Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol. 2011;12:722–734. doi: 10.1038/nrm3198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Lefterova MI, Lazar MA. New developments in adipogenesis. Trends Endocrinol Metab. 2009;20:107–114. doi: 10.1016/j.tem.2008.11.005. [DOI] [PubMed] [Google Scholar]
  • 4.Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149:274–293. doi: 10.1016/j.cell.2012.03.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Zhang HH, et al. Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway. PLoS One. 2009;4:e6189. doi: 10.1371/journal.pone.0006189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Tang Y, et al. Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism. Nat Commun. 2016;7:11365. doi: 10.1038/ncomms11365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Yoon MS, Zhang C, Sun Y, Schoenherr CJ, Chen J. Mechanistic target of rapamycin controls homeostasis of adipogenesis. J Lipid Res. 2013;54:2166–2173. doi: 10.1194/jlr.M037705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Polak P, et al. Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration. Cell Metab. 2008;8:399–410. doi: 10.1016/j.cmet.2008.09.003. [DOI] [PubMed] [Google Scholar]
  • 9.Cybulski N, Hall MN. TOR complex 2: a signaling pathway of its own. Trends Biochem Sci. 2009;34:620–627. doi: 10.1016/j.tibs.2009.09.004. [DOI] [PubMed] [Google Scholar]
  • 10.Garcia-Martinez JM, Alessi DR. mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1) Biochem J. 2008;416:375–385. doi: 10.1042/BJ20081668. [DOI] [PubMed] [Google Scholar]
  • 11.Di Pietro N, et al. Serum- and glucocorticoid-inducible kinase 1 (SGK1) regulates adipocyte differentiation via forkhead box O1. Mol Endocrinol. 2010;24:370–380. doi: 10.1210/me.2009-0265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Pearce LR, Sommer EM, Sakamoto K, Wullschleger S, Alessi DR. Protor-1 is required for efficient mTORC2-mediated activation of SGK1 in the kidney. Biochem J. 2011;436:169–179. doi: 10.1042/BJ20102103. [DOI] [PubMed] [Google Scholar]
  • 13.Murakami Y, et al. Identification of sites subjected to serine/threonine phosphorylation by SGK1 affecting N-myc downstream-regulated gene 1 (NDRG1)/Cap43-dependent suppression of angiogenic CXC chemokine expression in human pancreatic cancer cells. Biochem Biophys Res Commun. 2010;396:376–381. doi: 10.1016/j.bbrc.2010.04.100. [DOI] [PubMed] [Google Scholar]
  • 14.McCaig C, Potter L, Abramczyk O, Murray JT. Phosphorylation of NDRG1 is temporally and spatially controlled during the cell cycle. Biochem Biophys Res Commun. 2011;411:227–234. doi: 10.1016/j.bbrc.2011.06.092. [DOI] [PubMed] [Google Scholar]
  • 15.Inglis SK, et al. SGK1 activity in Na+ absorbing airway epithelial cells monitored by assaying NDRG1-Thr346/356/366 phosphorylation. Pflugers Arch. 2009;457:1287–1301. doi: 10.1007/s00424-008-0587-1. [DOI] [PubMed] [Google Scholar]
  • 16.Wang H, Liu L, Lin JZ, Aprahamian TR, Farmer SR. Browning of White Adipose Tissue with Roscovitine Induces a Distinct Population of UCP1+ Adipocytes. Cell Metab. 2016;24:835–847. doi: 10.1016/j.cmet.2016.10.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Wang H, Qiang L, Farmer SR. Identification of a domain within peroxisome proliferator-activated receptor gamma regulating expression of a group of genes containing fibroblast growth factor 21 that are selectively repressed by SIRT1 in adipocytes. Mol Cell Biol. 2008;28:188–200. doi: 10.1128/MCB.00992-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Kovacevic Z, et al. The Metastasis Suppressor, N-MYC Downstream-regulated Gene-1 (NDRG1), Down-regulates the ErbB Family of Receptors to Inhibit Downstream Oncogenic Signaling Pathways. J Biol Chem. 2016;291:1029–1052. doi: 10.1074/jbc.M115.689653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Sahni S, et al. The metastasis suppressor, N-myc downstream-regulated gene 1 (NDRG1), inhibits stress-induced autophagy in cancer cells. J Biol Chem. 2014;289:9692–9709. doi: 10.1074/jbc.M113.529511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Fang BA, et al. Molecular functions of the iron-regulated metastasis suppressor, NDRG1, and its potential as a molecular target for cancer therapy. Biochim Biophys Acta. 2014;1845:1–19. doi: 10.1016/j.bbcan.2013.11.002. [DOI] [PubMed] [Google Scholar]
  • 21.Stein S, et al. NDRG1 is necessary for p53-dependent apoptosis. J Biol Chem. 2004;279:48930–48940. doi: 10.1074/jbc.M400386200. [DOI] [PubMed] [Google Scholar]
  • 22.Murakami Y, et al. N-myc downstream-regulated gene 1 promotes tumor inflammatory angiogenesis through JNK activation and autocrine loop of interleukin-1alpha by human gastric cancer cells. J Biol Chem. 2013;288:25025–25037. doi: 10.1074/jbc.M113.472068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Okuda T, et al. Ndrg1-deficient mice exhibit a progressive demyelinating disorder of peripheral nerves. Mol Cell Biol. 2004;24:3949–3956. doi: 10.1128/MCB.24.9.3949-3956.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Echaniz-Laguna A, et al. NDRG1-linked Charcot-Marie-Tooth disease (CMT4D) with central nervous system involvement. Neuromuscul Disord. 2007;17:163–168. doi: 10.1016/j.nmd.2006.10.002. [DOI] [PubMed] [Google Scholar]
  • 25.Oh YM, et al. Ndrg1 is a T-cell clonal anergy factor negatively regulated by CD28 costimulation and interleukin-2. Nat Commun. 2015;6:8698. doi: 10.1038/ncomms9698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Watari K, et al. Impaired differentiation of macrophage lineage cells attenuates bone remodeling and inflammatory angiogenesis in Ndrg1 deficient mice. Sci Rep. 2016;6:19470. doi: 10.1038/srep19470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Sun J, et al. Metastasis suppressor, NDRG1, mediates its activity through signaling pathways and molecular motors. Carcinogenesis. 2013;34:1943–1954. doi: 10.1093/carcin/bgt163. [DOI] [PubMed] [Google Scholar]
  • 28.Wangpu X, et al. The metastasis suppressor, NDRG1, inhibits “stemness” of colorectal cancer via down-regulation of nuclear beta-catenin and CD44. Oncotarget. 2015;6:33893–33911. doi: 10.18632/oncotarget.5294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Lu WJ, Chua MS, Wei W, So SK. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3beta and Nur77 to prevent beta-catenin degradation. Oncotarget. 2015;6:29847–29859. doi: 10.18632/oncotarget.4913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Sugii S, et al. PPARgamma activation in adipocytes is sufficient for systemic insulin sensitization. Proc Natl Acad Sci USA. 2009;106:22504–22509. doi: 10.1073/pnas.0912487106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Kershaw EE, et al. PPARgamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo. Am J Physiol Endocrinol Metab. 2007;293:E1736–1745. doi: 10.1152/ajpendo.00122.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Deng T, et al. Peroxisome proliferator-activated receptor-gamma transcriptionally up-regulates hormone-sensitive lipase via the involvement of specificity protein-1. Endocrinology. 2006;147:875–884. doi: 10.1210/en.2005-0623. [DOI] [PubMed] [Google Scholar]
  • 33.Ross SE, Erickson RL, Hemati N, MacDougald OA. Glycogen synthase kinase 3 is an insulin-regulated C/EBPalpha kinase. Mol Cell Biol. 1999;19:8433–8441. doi: 10.1128/MCB.19.12.8433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Prusty D, Park BH, Davis KE, Farmer SR. Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARgamma) and C/EBPalpha gene expression during the differentiation of 3T3-L1 preadipocytes. J Biol Chem. 2002;277:46226–46232. doi: 10.1074/jbc.M207776200. [DOI] [PubMed] [Google Scholar]
  • 35.Liu J, Farmer SR. Regulating the balance between peroxisome proliferator-activated receptor gamma and beta-catenin signaling during adipogenesis. A glycogen synthase kinase 3beta phosphorylation-defective mutant of beta-catenin inhibits expression of a subset of adipogenic genes. J Biol Chem. 2004;279:45020–45027. doi: 10.1074/jbc.M407050200. [DOI] [PubMed] [Google Scholar]
  • 36.Lamming DW, Sabatini DM. A Central role for mTOR in lipid homeostasis. Cell Metab. 2013;18:465–469. doi: 10.1016/j.cmet.2013.08.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Liu HK, et al. Functional characterisation of the regulation of CAAT enhancer binding protein alpha by GSK-3 phosphorylation of Threonines 222/226. BMC Mol Biol. 2006;7:14. doi: 10.1186/1471-2199-7-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Fellmann C, et al. An optimized microRNA backbone for effective single-copy RNAi. Cell Rep. 2013;5:1704–1713. doi: 10.1016/j.celrep.2013.11.020. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary information (748.2KB, pdf)

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES